Peptide Therapy in Boca Raton
Peptides Are Serious Medicine. Take Them Seriously.
Peptide therapy sits in an unusual place: legitimate biological compounds with a growing body of supporting research, genuinely useful for the right patients — surrounded by a market so saturated with unregulated products and unqualified prescribers that it’s become hard to know what’s credible.
Dr. Jeffrey Stein’s approach is direct. Peptides are prescribed compounds with biological activity. They require patient evaluation, appropriate compound selection, verified compounding sources, monitoring, and a physician who’s accountable for the outcome. At Boca Raton Concierge Medicine, peptide therapy is offered within that framework — as part of a comprehensive clinical plan, not an add-on or a supplement recommendation.
Growth Hormone Secretagogues
Among the most clinically studied peptides are growth hormone secretagogues — compounds that stimulate the pituitary’s natural GH production rather than introducing exogenous GH directly. CJC-1295 combined with ipamorelin is one of the most widely used protocols.
By stimulating pulsatile growth hormone release in a pattern that approximates the body’s natural rhythm, secretagogue therapy can support body composition, sleep quality, recovery, and tissue repair in patients whose GH output has declined with age.
For appropriate candidates — typically adults over 35 with symptomatic decline confirmed on evaluation — Dr. Stein manages these protocols with IGF-1 monitoring, baseline cardiovascular assessment, and attention to individual factors affecting both efficacy and risk. The goal is restoration of physiological function, not pharmacological augmentation.
Tissue Repair and Recovery — BPC-157
BPC-157 is a synthetic peptide with substantial preclinical research supporting its role in accelerating tissue healing — tendon, ligament, muscle, and gastrointestinal. Human clinical trial data remains limited, but the mechanistic evidence is strong and the safety profile in available research is favorable. For members dealing with musculoskeletal injuries, post-surgical recovery, or chronic soft tissue conditions that haven’t responded to standard treatment, Dr. Stein will discuss BPC-157 with an honest assessment of what the evidence currently supports.
PT-141 and Sexual Health
Thymosin Alpha-1 and Immune Function
Evaluation Comes First. Always.
There is no responsible peptide protocol that starts with compound selection. It starts with you — your health history, your goals, your concurrent medications, your laboratory profile, and the specific mechanism by which a given peptide is hypothesized to benefit you.
That evaluation happens as part of Dr. Stein’s comprehensive concierge care relationship. Peptide decisions are made with full clinical context, not in isolation. Raise it directly in a consultation — he’ll tell you exactly what the evidence supports, what he recommends for your situation, and what monitoring makes sense.


